Joliet Hematology Associates

Joliet, Illinois 60435

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, NSCLC, Non-small Cell Lung Cancer

Studies at this site

• Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC) — Completed